Preclinical

The Importance of Conducting PDX Oncology Studies in a Humanized Immune System

Preclinical

The Importance of Conducting PDX Oncology Studies in a Humanized Immune System

The Importance of Incorporating Metabolomic and Proteomic Screening in Preclinical Oncology Studies

Preclinical

The Importance of Incorporating Metabolomic and Proteomic Screening in Preclinical Oncology Studies

Choosing the Right DIO Mouse Model for Your Oncology Study

Preclinical

Choosing the Right DIO Mouse Model for Your Oncology Study

Harnessing the Capabilities of Aura Imaging Software 4.0 in Preclinical Oncology Research

Preclinical

Harnessing the Capabilities of Aura Imaging Software 4.0 in Preclinical Oncology Research

Predictive Value of CDX Models: Bridging Preclinical and Clinical Research

Preclinical

Predictive Value of CDX Models: Bridging Preclinical and Clinical Research

Unlocking the Potential: Optical Luminescence vs. Fluorescence Imaging in Preclinical Oncology Research

Preclinical

Unlocking the Potential: Optical Luminescence vs. Fluorescence Imaging in Preclinical Oncology Research

Top Trends in ADC Drug Development

Preclinical

Top Trends in ADC Drug Development

Unlocking Insights: Top 5 Reasons to Incorporate Orthotopic GBM PDX Models into Your Preclinical Evaluation

Preclinical

Unlocking Insights: Top 5 Reasons to Incorporate Orthotopic GBM PDX Models into Your Preclinical Evaluation

 

Preclinical

Enhancing Immuno-Oncology Research: Top 5 Essential Flow Cytometry Assays

The Significance of Preclinical Evaluation in CAR T-cell Therapy for Solid and Hematologic Tumors

Preclinical

The Significance of Preclinical Evaluation in CAR T-cell Therapy for Solid and Hematologic Tumors

Advancing Preclinical Cancer Research Through Metabolomics: Key Strategies for Biomarker Identification and Drug-Target Analysis in Immuno-Oncology

Preclinical

Advancing Preclinical Cancer Research Through Metabolomics: Key Strategies for Biomarker Identification and Drug-Target Analysis in Immuno-Oncology

Orthotopic vs. Subcutaneous: Unpacking the Strengths and Limitations of Tumor Model Implantation Sites

Preclinical

Orthotopic vs. Subcutaneous: Unpacking the Strengths and Limitations of Tumor Model Implantation Sites

Unveiling the Potential: 5 Ways DIO Mice Enhance Immuno-Oncology Discoveries

Preclinical

Unveiling the Potential: 5 Ways DIO Mice Enhance Immuno-Oncology Discoveries

Genetically Engineered Humanized Mouse Models: A Critical Tool for Studying Immunotherapy Drugs

Preclinical

Genetically Engineered Humanized Mouse Models: A Critical Tool for Studying Immunotherapy Drugs

Diet-Induced Obesity Tumor Models for Cancer Studies

Preclinical

Diet-Induced Obesity Tumor Models for Cancer Studies

CAR T-cell Therapy Program Development: Key Considerations

Preclinical

CAR T-cell Therapy Program Development: Key Considerations

 

Preclinical

Maximizing Reproducibility in Cancer Research

 

Preclinical

Will Your Cancer Drug Move Past Phase 1?

 

Preclinical

The Missing Step Between Phase I and Phase II

 

Preclinical

Now Available: Liver Fibrosis Models Fed Choline-Deficient, High-Fat Diets

 

Preclinical

The Keto Diet and Cancer Research: New Insights Emerge

 

Preclinical

In Vitro vs. In Vivo Preclinical Drug Testing

 

Preclinical

Future Trends for Oncology Drug Development

 

Preclinical

Research Review: 4 Secrets for Preclinical Success